Douglas Maffei | Senior Director, IR |
Daniel O'Day | Chairman and CEO |
Johanna Mercier | Chief Commercial Officer |
Merdad Parsey | Chief Medical Officer |
Andrew Dickinson | CFO |
Diana Brainard | SVP and Head, Virology Therapeutic Area |
Matthew Harrison | Morgan Stanley |
Evan Seigerman | Credit Suisse |
Cory Kasimov | JP Morgan |
Michael Yee | Jefferies |
Geoffrey Porges | SVB Leerink |
Alethia Young | Cantor Fitzgerald |
Carter Gould | Barclays |
Brian Abrahams | RBC Capital Markets |
Tyler Van Buren | Piper Sandler |
Umer Raffat | Evercore |
Geoff Meacham | Bank of America |
Ladies and gentlemen, thank you for standing by, and welcome to the Third Quarter 2020 Gilead Sciences Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today to Douglas Maffei, Senior Director of Investor Relations.